Corporate Banner
Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>Events>This Event
  Events - November 2012

Clinical Trials in CNS

05 Nov 2012 - 06 Nov 2012 - London, UK

Bookmark and Share

The SMi Group is proud to present their 11th annual Clinical Trials in CNS conference that will discuss the latest developments in preclinical discovery, clinical trial design, clinical trial management and the latest developments in neurodegenerative treatments.

Key reasons to attend:

· Learn of the latest drug developments combating the key diseases in CNS, from Alzheimer's and dementia, to depression and schizophrenia 

· Discuss the cutting issues of the industry, from the ethics of outsourcing, to proving efficacy 

· Explore the latest innovations in pre-clinical discovery, trial optimisation and biomarker identification 

· Discover new ways to manage and adapt a clinical trial to ensure its success and efficiency  

· Network with key members of the industry involved in every part of clinical trials: from bench to   bedside 

Key Speakers Include:

· Johan Luthman, Senior Programme Leader, Merck & Co.

· Florian Von Raison, Global Program Head, Novartis

· Michael O’Neill, Senior Research Advisor, Eli Lilly

· Bruno Pitrosky, Global Program Lead, Primary Care, Pfizer PGRD

· Lars Bauer, Senior Medical Director, TA CNS, UCB Biosciences GmbH

· Frank Miller, Senior Statistician and Principal Scientist, AstraZeneca

Further information
Scientific News
High Throughput Mass Spectrometry-Based Screening Assay Trends
Dr John Comley provides an insight into HT MS-based screening with a focus on future user requirements and preferences.
Revolutionary Technologies Developed to Improve Outcomes for Lung Cancer Patients
Breath test to detect lung cancer brings oxygen directly to the wound.
NIH Supports New Studies to Find Alzheimer’s Biomarkers in Down Syndrome
Initiative will track dementia onset, progress in Down syndrome volunteers.
Dementia Linked to Deficient DNA Repair
Mutant forms of breast cancer factor 1 (BRCA1) are associated with breast and ovarian cancers but according to new findings, in the brain the normal BRCA1 gene product may also be linked to Alzheimer’s disease.
Using Drug-Susceptible Parasites to Fight Drug Resistance
Researchers at the University of Georgia have developed a model for evaluating a potential new strategy in the fight against drug-resistant diseases.
Boosting Breast Cancer Treatment
To more efficiently treat breast cancer, scientists have been researching molecules that selectively bind to cancer cells and deliver a substance that can kill the tumor cells, for several years.
New Gene Map Reveals Cancer’s Achilles’ Heel
Team of researchers switches off almost 18,000 genes
New Discovery Sheds Light on Disease Risk
Gaps between genes interact to influence the risk of acquiring disease.
How Cells ‘Climb’ to Build Fruit Fly Tracheas
Mipp1 protein helps cells sprout “fingers” for gripping.
Research Finding Could Lead to Targeted Therapies for IBD
Findings published online in Cell Reports.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos